This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Swanson-Mungerson, M. A. Articles by Longnecker, R. Search for Related Content PubMed PubMed Citation Articles by Swanson-Mungerson, M. A. Articles by Longnecker, R.

Epstein-Barr Virus LMP2A Alters In Vivo and In Vitro Models of B-Cell Anergy, but Not Deletion, in Response to Autoantigen

Department of Microbiology and Immunology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611

Received 17 September 2004/ Accepted 2 February 2005

A significant percentage of the population latently harbors Epstein-Barr virus (EBV) in B cells. One EBV-encoded protein, latent membrane protein 2A (LMP2A), is expressed in tissue culture models of EBV latent infection, in human infections, and in many of the EBV-associated proliferative disorders. LMP2A constitutively activates proteins involved in the B-cell receptor (BCR) signal transduction cascade and inhibits the antigen-induced activation of these proteins. In the present study, we investigated whether LMP2A alters B-cell receptor signaling in primary B cells in vivo and in vitro. LMP2A does not inhibit antigen-induced tolerance in response to strong stimuli in an in vivo tolerance model in which B cells are reactive to self-antigen. In contrast, LMP2A bypasses anergy induction in response to low levels of soluble hen egg lysozyme (HEL) both in vivo and in vitro as determined by the ability of LMP2A-expressing HEL-specific B cells to proliferate and induce NF-B nuclear translocation after exposure to low levels of antigen. Furthermore, LMP2A induces NF-B nuclear translocation independent of BCR cross-linking. Since NF-B is required to bypass tolerance induction, this LMP2A-dependent NF-B activation may complete the tolerogenic signal induced by low levels of soluble HEL. Overall, the findings suggest that LMP2A may not inhibit BCR-induced signals under all conditions as previously suggested by studies with EBV immortalized B cells.

This article has been cited by other articles:

• Anderson, L. J., Longnecker, R. (2008). EBV LMP2A provides a surrogate pre-B cell receptor signal through constitutive activation of the ERK/MAPK pathway. J. Gen. Virol. 89: 1563-1568 [Abstract] [Full Text]  
• Guasparri, I., Bubman, D., Cesarman, E. (2008). EBV LMP2A affects LMP1-mediated NF-{kappa}B signaling and survival of lymphoma cells by regulating TRAF2 expression. Blood 111: 3813-3820 [Abstract] [Full Text]  
• Fukuda, M., Longnecker, R. (2007). Epstein-Barr Virus Latent Membrane Protein 2A Mediates Transformation through Constitutive Activation of the Ras/PI3-K/Akt Pathway. J. Virol. 81: 9299-9306 [Abstract] [Full Text]  
• Souza, T. A., Stollar, B. D., Sullivan, J. L., Luzuriaga, K., Thorley-Lawson, D. A. (2007). Influence of EBV on the Peripheral Blood Memory B Cell Compartment. J. Immunol. 179: 3153-3160 [Abstract] [Full Text]  
• Wang, H., Nicholas, M. W., Conway, K. L., Sen, P., Diz, R., Tisch, R. M., Clarke, S. H. (2006). EBV Latent Membrane Protein 2A Induces Autoreactive B Cell Activation and TLR Hypersensitivity.. J. Immunol. 177: 2793-2802 [Abstract] [Full Text]  
• Swanson-Mungerson, M., Bultema, R., Longnecker, R. (2006). Epstein-Barr Virus LMP2A Enhances B-Cell Responses In Vivo and In Vitro. J. Virol. 80: 6764-6770 [Abstract] [Full Text]  
• Lu, J., Lin, W.-H., Chen, S.-Y., Longnecker, R., Tsai, S.-C., Chen, C.-L., Tsai, C.-H. (2006). Syk Tyrosine Kinase Mediates Epstein-Barr Virus Latent Membrane Protein 2A-induced Cell Migration in Epithelial Cells. J. Biol. Chem. 281: 8806-8814 [Abstract] [Full Text]  
• Souza, T. A., Stollar, B. D., Sullivan, J. L., Luzuriaga, K., Thorley-Lawson, D. A. (2005). Peripheral B cells latently infected with Epstein-Barr virus display molecular hallmarks of classical antigen-selected memory B cells. Proc. Natl. Acad. Sci. USA 102: 18093-18098 [Abstract] [Full Text]